Identification of an irreversible PPARγ antagonist with potent anticancer activity

Abstract Melanoma is responsible for most skin cancer deaths, and its incidence continues to rise year after year. Different treatment options have been developed for melanoma depending on the stage of the disease. Despite recent advances in immuno‐ and targeted therapies, advanced melanoma remains...

Full description

Bibliographic Details
Main Authors: Youyi Peng, Qiang Zhang, Robert M. Zielinski, Richard D. Howells, William J. Welsh
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.693